to stop

The only hope for an influenza pandemic, as we now come before the vaccine against bird flu, a “universal” flu, we develop Innoculate against all influenza viruses.

This would also in the habit of the people a new flu shot every autumn.

The European Union is funding a collaborative project called universal vaccine to produce a vaccine for people permanantly vaccinated against all strains of influenza A and B influenza.

plan, the M2e domain of the M2 protein ion channel extracullular that in all influenza A-type focus maintained. This exceeds the M2 ectodomain consists of 23 amino acids. Walter Fiers, co-inventor of the process said: “The structure of the M2 protein is nearly identical in all known flu virus can be transmitted between people.”

previous vaccines focus on hemagglutinin (H) and neuraminidase protein (N) protein spikes that are coming out of the fatty sheath around the 8 subjects of the influenza virus. However, tests showed that the M2 protein remained relatively constant since the influenza virus was first isolated in 1933.

schedule, the vaccine using recombinant bacterial fermentation to produce faster, cheaper and more efficient than conventional techniques flu always eggs

hope you human studies begin in spring 2007

included in the vaccine are universal: .. Arexis AB, Sweden; Pepscan Systems BV, Netherlands; Proxima Concepts Ltd., England. Eurogentec SA, Belgium, Flanders Interuniversity Institute for Biotechnology VZW (VIB), Belgium and the University of Gothenburg (UGOT), Sweden

Merck is also working on a universal vaccine based targeting M2.

San Diego-based Vical Incorporated is working on a vaccine against H5N1, and believes he held on to the keys to a vaccine against pandemic flu They have their vaccine, which focuses on three bits of DNA: .. the H5 protein, the nucleoprotein (NP) and matrix protein, the M2

Using

conserved protein internal nucleoprotein (NP) raises a different kind of immunity. It is the type of T-cell-based called cytotoxic T lymphocytes (CTL) rather than antibodies. These CTL kill cells infected with influenza virus.

Rats and ferrets vaccinated with this vaccine

not only contact with H5N1 survived, but usually the human influenza virus as well.

L Israeli companies BiondVax Pharmaceuticals is working on a universal flu vaccination for two years. Their vaccine is inhaled, and they expect protection from 95% of all flu offer, including H5N1, and that the protection for a period of five years.

Your vaccine based on 15 years of research by Weizmann Institute Professor Ruth Arnon. She worked on the search for conserved epitopes, fragments of the outer shell of the virus that never change, despite the antigenic shift and drift. She found that hemaggluttin hid a peptide that is fixed.

BiondVax expected development time to take three to four years, much shorter if an avian flu pandemic hits.

“Dr. Arnon decided to not to pursue a specific strain of the virus, she said:” We will identify the elements that duplicate for all influenza virus The use of genetic engineering, these common parts of the virus, and create a vaccine, -. no matter what virus will -. to get vaccinated, “said one of the founders of Devash

BiondVax

One thing we based on universal vaccine M2 protein has to understand, however, is that we are still sick. This is because our body produces antibodies to bind M2 cells produce that’re already infected and to promote their game from the body, but not prevent them infected in the first place.

This influenza virus can infect even enter your body and lungs. However, the infection do not spread as easily. You can always ill, but probably not die.

vaccines against neuro internal protein NP -. the same problem, they promote the killing of infected cells, but did not prevent infections

Vaccine against influenza